Raise by Fusion42
Fusion42 Scout Wire
Capital Reports
Who's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC
Benchmarks
Benchmarks HomeFundsRoundsSectors
AI VC IndexCapital FlowAbout

Switch product

Fusion42RaiseScoutWire

Capital Reports

All editionsWho's InvestingWeekly · Mon 08:00 UTCCapital UnlockedBi-weekly · Wed 08:00 UTC

Database & benchmarks

Benchmarks HomeFundsRoundsSectorsStagesAI VC IndexCapital Flow Index

Account

Sign in
← Back

Third Rock Ventures VII

vc$1.1BCo-investsLeads rounds

◆ Fund Size

$1.1B

◆ Check Size

$1.5M→$50.0M

◆ Location

United States

◆ Portfolio

7 companies

◆ Activity

Statusactively investing

◆ Links

Website ↗@ThirdRockVC on X ↗

◆ Share this fund

ShareXLinkedInEmail

◆ Investment Thesis

Third Rock Ventures invests where major scientific advances can be translated into transformative medicines and healthcare products, especially in areas with high unmet medical need. Its approach is to actively participate in company creation rather than passively fund existing startups, pairing breakthrough science with operational support, strategy, leadership recruiting, and clinical-development expertise to increase the odds of building category-defining life sciences companies.

◆ About Third Rock Ventures

Third Rock Ventures is a healthcare and life sciences venture firm focused on advancing disruptive science and medicine. It takes a hands-on company-formation approach, often working with scientific founders and experts from the earliest stages to build new biotech and health-focused companies.

◆ Sectors

Drug DiscoveryMedtechDiagnostics

◆ Stages

pre-seedseedseries-aseries-b

◆ Geography Focus

East CoastWest Coast

◆ Team

NameTitleRoleLinks
Danielle AbdelahadVice President, Head of PeopleSeniorin
Gabriella WilliamsSenior Director, Management Company ControllerSeniorin
Bob TepperCo-founder—
Kevin StarrCo-founder—
Lisa PurcellEntrepreneur-in-ResidenceEntrepreneur-in-Residencein
Mark LevinCo-founder—

◆ Notable Investments

ModernaSage TherapeuticsRapt TherapeuticsGenerate:BiomedicinesRelay TherapeuticsCandid TherapeuticsTango TherapeuticsAzalea TherapeuticsMarea TherapeuticsSeaport TherapeuticsMerida BiosciencesARTBIOMaze TherapeuticsTrace NeuroscienceGlobal Blood TherapeuticsBlueprint MedicinesBluebird BioEditas MedicineDecibel TherapeuticsSynnovation Therapeutics

◆ Traits

Leads rounds

Co-invests

◆ FAQ

What does Third Rock Ventures VII invest in?

Third Rock Ventures VII invests in Drug Discovery, Medtech and Diagnostics at the pre-seed, seed, series-a and series-b stages.

Which geographies does Third Rock Ventures VII focus on?

Third Rock Ventures VII focuses on East Coast and West Coast, and is headquartered in United States.

What is Third Rock Ventures VII's typical check size?

Third Rock Ventures VII typically writes checks of $1.5M to $50M.